Provided by Tiger Fintech (Singapore) Pte. Ltd.

Axsome Therapeutics

112.29
+2.382.16%
Pre-market: 114.992.70+2.40%09:20 EDT
Volume:708.93K
Turnover:79.23M
Market Cap:5.48B
PE:-18.73
High:113.00
Open:109.94
Low:109.59
Close:109.92
Loading ...

Axsome Therapeutics and Mental Health America (MHA) Join Voices to Highlight Mental Health Month

GlobeNewswire
·
2 hours ago

Axsome Therapeutics Is Maintained at Outperform by RBC Capital

Dow Jones
·
Yesterday

Analysts Are Bullish on These Healthcare Stocks: Axsome Therapeutics (AXSM), Alnylam Pharma (ALNY)

TIPRANKS
·
29 Apr

Axsome Therapeutics Inc : RBC Raises Target Price to $193 From $190

THOMSON REUTERS
·
29 Apr

UBS Adjusts Axsome Therapeutics Price Target to $143 From $149, Maintains Buy Rating

MT Newswires Live
·
28 Apr

Axsome Therapeutics to Participate in Upcoming Investor Conferences

GlobeNewswire
·
22 Apr

Top Analyst Reports for Apple, Philip Morris & Sony

Zacks
·
18 Apr

Axsome (AXSM) Moves 4.2% Higher: Will This Strength Last?

Zacks
·
10 Apr

Top Research Reports for Verizon, The Southern Co. & Blackstone

Zacks
·
08 Apr

Axsome Therapeutics Initiated at Buy by Jefferies

Dow Jones
·
07 Apr

Axsome Therapeutics: Promising CNS Pipeline and Growth Potential Justify Buy Rating

TIPRANKS
·
07 Apr

Axsome Therapeutics Presents Positive Pivotal Phase 3 Results of the ACCORD-2 Trial of AXS-05 in Alzheimer’s Disease Agitation and the SYMPHONY Trial of AXS-12 in Narcolepsy at the 2025 American Academy of Neurology (AAN) Annual Meeting

GlobeNewswire
·
04 Apr

Axsome Therapeutics Price Target Maintained With a $200.00/Share by HC Wainwright & Co.

Dow Jones
·
03 Apr

RBC Trims Price Target on Axsome Therapeutics to $190 From $192, Keeps Outperform Rating

MT Newswires Live
·
03 Apr

Biotech Stock Roundup: CORT Up on Study Data, Updates From AXSM, BMY, EXEL & More

Zacks
·
03 Apr

Alkermes Begins Idiopathic Hypersomnia Study on ALKS 2680

Zacks
·
02 Apr

Deutsche Bank Adjusts Axsome Therapeutics Price Target to $187 From $200, Maintains Buy Rating

MT Newswires Live
·
02 Apr

Axsome Therapeutics Inc. : Deutsche Bank Cuts Target Price to $187 From $200

THOMSON REUTERS
·
02 Apr

Why Shares of Axsome Therapeutics Slumped Today

Motley Fool
·
02 Apr

Axsome Therapeutics Shares Down 4.5% After Co's Depression Treatment Fails to Meet Main Goal of Late-Stage Study

THOMSON REUTERS
·
01 Apr